Texas Ophthalmological Association

Blieden discusses long-term patient management in glaucoma, the importance of follow-up care, and the role of advocacy in ophthalmology.

Blieden describes recent advancements in the detection and treatment of narrow-angle glaucoma at TOA 2025.

McCulley examines the latest updates on GLP-1 receptor agonists relevant for ophthalmologists and patients with ophthalmic diseases at TOA 2025.

Study draws correlative connection between semaglutide and nonarteritic anterior ischemic optic neuropathy, more data required to show causation.

Research presents a correlation between the index and age-related macular degeneration and suggests a causal relationship.

The study proves that cataract, glaucoma, and age-related eye disease can be exacerbated by exposure to several common pollutants simultaneously.

Khandelwal discusses advancements in intraocular lens (IOL) categories and the patient's role in choosing more innovative options.

Khandelwal shares insight and key takeaways for the optimization of intraocular lens selection in practice.

Repka describes the complications of the US healthcare system and how to advance interactions in advocacy efforts.

Repka dives into the role of advocacy in shaping ophthalmologic policies and ensuring equitable patient care.